Guided Therapeutics, Inc.
GTHP
$0.20
-$0.03-12.28%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.27M | -3.20M | -2.63M | -2.54M | -2.44M |
| Total Depreciation and Amortization | 106.00K | 107.00K | 103.00K | 100.00K | 97.00K |
| Total Amortization of Deferred Charges | 225.00K | 244.00K | 227.00K | 195.00K | 145.00K |
| Total Other Non-Cash Items | 717.00K | 788.00K | 405.00K | 311.00K | 67.00K |
| Change in Net Operating Assets | 867.00K | 989.00K | 786.00K | 631.00K | 783.00K |
| Cash from Operations | -1.35M | -1.07M | -1.11M | -1.31M | -1.35M |
| Capital Expenditure | -2.00K | -2.00K | -2.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -2.00K | -2.00K | -- | -- |
| Total Debt Issued | 731.00K | 543.00K | 618.00K | 742.00K | 587.00K |
| Total Debt Repaid | -610.00K | -540.00K | -552.00K | -510.00K | -578.00K |
| Issuance of Common Stock | 1.55M | 772.00K | 1.00M | 1.04M | 1.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -58.00K | -30.00K | -62.00K | -57.00K | -29.00K |
| Cash from Financing | 1.61M | 745.00K | 1.00M | 1.22M | 1.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 254.00K | -325.00K | -107.00K | -90.00K | -330.00K |